论文部分内容阅读
目的非小细胞肺癌的免疫功能。方法以病理组织学或细胞学检查确诊的非小细胞肺癌71例。治疗组41例,采用MVP方案配合平消胶囊治疗,即丝裂霉素(MMC)长春花碱酰胺(VDS)顺铂(DDP)。平消胶囊六粒,每日3次口服,连用4周为一周期。对照组30例,仅采用MVP方案化疗。结果对照组化疗前后的白细胞总数淋巴细胞总数有显著改变,而治疗组无显著改变。结论平消胶囊配合化疗治非小细胞肺癌,可使患者外周血象中白细胞淋巴细胞总数以及红细胞免疫功能有保护作用。对治疗非小细胞肺癌有抗癌增效作用。
Objective Immune function of non-small cell lung cancer. Methods Totally 71 cases of non-small cell lung cancer diagnosed by histopathology or cytology. The treatment group, 41 cases, using MVP program with Pingxiao capsule treatment, that mitomycin (MMC) vinblastine (VDS) cisplatin (DDP). Ping capsule six capsules three times a day orally, once every 4 weeks for a cycle. Control group, 30 cases, only chemotherapy with MVP regimen. Results The total number of leukocytes in the control group before and after chemotherapy had a significant change in the total number of lymphocytes, but no significant change in the treatment group. Conclusion Pingxiao capsule combined with chemotherapy in the treatment of non-small cell lung cancer can make the total number of peripheral leukocytes and the protective effect of erythrocyte immune function. On the treatment of non-small cell lung cancer have anti-cancer synergy.